Related references
Note: Only part of the references are listed.Time-Dependent Diaryl Ether Inhibitors of InhA: Structure-Activity Relationship Studies of Enzyme Inhibition, Antibacterial Activity, and in vivo Efficacy
Pan Pan et al.
CHEMMEDCHEM (2014)
In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin
Jennifer A. Leeds et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor
Johannes Schiebel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA
Lourdes Encinas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds
Pan Pan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
Ruben C. Hartkoorn et al.
EMBO MOLECULAR MEDICINE (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Phosphorylation of InhA inhibits mycolic acid biosynthesis and growth of Mycobacterium tuberculosis
Virginie Molle et al.
MOLECULAR MICROBIOLOGY (2010)
Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis
Joel S. Freundlich et al.
CHEMMEDCHEM (2009)
Artificial Membrane Assays to Assess Permeability
Bernard Faller
CURRENT DRUG METABOLISM (2008)
The mechanism of isoniazid killing: Clarity through the scope of genetics
Catherine Vilcheze et al.
ANNUAL REVIEW OF MICROBIOLOGY (2007)
Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis
Peter J. Tonge et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
High-throughput in vitro profiling assays:: lessons learnt from experiences at Novartis
Bernard Faller et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA
Hongling Guo et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis
Xin He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Catherine Vilcheze et al.
NATURE MEDICINE (2006)
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
UH Manjunatha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites
MM Gutacker et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Scaling and assessment of data quality
P Evans
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis
Todd J. Sullivan et al.
ACS CHEMICAL BIOLOGY (2006)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance
R Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Absorption rate limit considerations for oral phosphate prodrugs
T Heimbach et al.
PHARMACEUTICAL RESEARCH (2003)
Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis
SV Ramaswamy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid
SL Parikh et al.
BIOCHEMISTRY (2000)
Share Paper
